Related Experiment Video
Updated: Aug 19, 2025

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Cellular and molecular effects of PNCK, a non-canonical kinase target in renal cell carcinoma
Derek J Essegian1, Valery Chavez2, Floritza Bustamante2
1Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Abstract:
Renal cell carcinoma (RCC) is a fatal disease when advanced. While immunotherapy and tyrosine kinase inhibitor-based combinations are associated with improved survival, the majority of patients eventually succumb to the disease. Through a comprehensive pan-cancer, pan-kinome analysis of the Cancer Genome Atlas (TCGA), pregnancy-upregulated non-ubiquitous calcium-calmodulin-dependent kinase (PNCK), was identified as the most differentially overexpressed kinase in RCC. PNCK overexpression correlated with tumor stage, grade and poor survival. PNCK overexpression in RCC cells was associated with increased CREB phosphorylation, increased cell proliferation, and cell cycle progression. PNCK down-regulation, conversely, was associated with the opposite, in addition to increased apoptosis. Pathway analyses in PNCK knockdown cells showed significant down-regulation of hypoxia and angiogenesis pathways, as well as the modulation of the cell cycle, DNA damage, and apoptosis pathways. These results demonstrate for the first time the biological role of PNCK, an understudied kinase, in RCC and validate PNCK as a druggable target.
Insights
Pregnancy-upregulated non-ubiquitous calcium-calmodulin-dependent kinase (PNCK) is highly overexpressed in advanced renal cell carcinoma (RCC), driving tumor growth and poor survival. Targeting PNCK presents a promising new therapeutic strategy for this fatal cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Advanced renal cell carcinoma (RCC) remains a significant cause of cancer mortality, with current treatments offering limited long-term efficacy for many patients.
- Despite advances in immunotherapy and tyrosine kinase inhibitors, a substantial proportion of patients with advanced RCC eventually succumb to the disease, highlighting the need for novel therapeutic targets.
Purpose of the Study:
- To identify novel therapeutic targets in renal cell carcinoma (RCC) by conducting a comprehensive pan-cancer, pan-kinome analysis.
- To investigate the biological role and clinical significance of pregnancy-upregulated non-ubiquitous calcium-calmodulin-dependent kinase (PNCK) in RCC progression and patient outcomes.
Main Methods:
- Utilized the Cancer Genome Atlas (TCGA) for a pan-cancer, pan-kinome analysis to identify differentially overexpressed kinases in RCC.
- Performed functional studies involving PNCK knockdown in RCC cells to assess its impact on cell proliferation, apoptosis, cell cycle, and key signaling pathways.
- Conducted pathway analyses to elucidate the molecular mechanisms regulated by PNCK in RCC.
Main Results:
- Pregnancy-upregulated non-ubiquitous calcium-calmodulin-dependent kinase (PNCK) was identified as the most differentially overexpressed kinase in RCC across the TCGA dataset.
- PNCK overexpression positively correlated with advanced tumor stage, higher tumor grade, and poorer patient survival.
- PNCK knockdown led to decreased cell proliferation, cell cycle progression, and increased apoptosis, alongside significant downregulation of hypoxia and angiogenesis pathways.
Conclusions:
- This study establishes the critical role of PNCK in the pathogenesis of renal cell carcinoma (RCC), demonstrating its involvement in tumor progression and survival.
- The findings validate PNCK as a novel, druggable target for therapeutic intervention in advanced RCC.
- Further research into PNCK-targeted therapies holds significant promise for improving outcomes in patients with this aggressive cancer.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Negative Regulator Molecules
Abnormal Proliferation
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

